Overview of NDC: 75834-0265
The NDC code 75834-0265 corresponds to Diclofenac Sodium and Misoprostol, a combination drug manufactured by Nivagen Pharmaceuticals, Inc. This medication is used to treat pain, inflammation, and stomach ulcers associated with nonsteroidal anti-inflammatory drugs (NSAIDs) like diclofenac.
Market Context
Pharmaceutical Market Trends
The pharmaceutical market, particularly for specialty and chronic condition treatments, is experiencing significant growth and price inflation. According to Vizient, Inc., drug price inflation is projected to grow at 3.8% in 2024, driven largely by specialty pharmaceuticals, including those for chronic and complex conditions[2].
Biopharma and Biotech Sector Growth
The biopharma and biotech industries are also seeing rapid growth, with the biopharma market size estimated to be over $400 billion in 2024 and projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029. This growth is fueled by advancements in technology, evolving regulatory frameworks, and a shift towards patient-centered care[3].
Specific Market Analysis for Diclofenac Sodium and Misoprostol
Market Size and Growth
While the specific market size for Diclofenac Sodium and Misoprostol (NDC: 75834-0265) is not provided, the broader market for NSAIDs and gastrointestinal protective agents is substantial. The global market for gastrointestinal drugs, which includes medications like diclofenac and misoprostol, is driven by the increasing prevalence of gastrointestinal disorders and the need for effective treatments.
Price Projections
Given the overall trend of drug price inflation, it is likely that the price of Diclofenac Sodium and Misoprostol will increase. Here are some key points to consider:
- General Drug Price Inflation: With a projected 3.8% increase in drug prices overall, it is reasonable to expect that the price of Diclofenac Sodium and Misoprostol will also rise, although the exact percentage may vary[2].
- Specialty and Chronic Condition Treatments: Since this medication is used for chronic conditions, it may be subject to the higher price inflation rates seen in specialty pharmaceuticals, which are projected at 4.18% for 2024[2].
- Market Competition: The presence of generic and branded competitors can influence pricing. However, as a combination drug, Diclofenac Sodium and Misoprostol may maintain a competitive edge due to its specific formulation and therapeutic benefits.
Competitive Landscape
The competitive landscape for Diclofenac Sodium and Misoprostol includes both branded and generic versions of the drug. Here are some factors to consider:
- Generic Competition: Generic versions of diclofenac and misoprostol are available, which can put downward pressure on prices. However, the combination formulation may still command a premium due to its convenience and therapeutic efficacy.
- Biosimilars and Generics: The trend towards biosimilars and generics gaining market share, as seen with drugs like Humira®, could impact the pricing strategy for Diclofenac Sodium and Misoprostol. However, this is more relevant to biologic drugs rather than small molecule drugs like diclofenac[2].
Regulatory and Technological Factors
Regulatory Landscape
The regulatory environment is evolving to keep pace with innovation in the biopharma and biotech sectors. This evolution can impact the approval and pricing of new and existing drugs. For Diclofenac Sodium and Misoprostol, any changes in regulatory requirements or approvals could influence pricing and market access[3].
Technological Advancements
Technological advancements, such as accelerated clinical trial designs and the use of AI/ML in drug development, are reshaping the pharmaceutical industry. While these advancements are more relevant to new drug development, they can also influence the pricing and market positioning of existing drugs by setting new standards for efficacy and safety[3].
Key Takeaways
- Price Inflation: Expect a price increase for Diclofenac Sodium and Misoprostol in line with the overall trend of drug price inflation.
- Market Growth: The market for gastrointestinal protective agents is substantial and growing, driven by the increasing prevalence of gastrointestinal disorders.
- Competitive Landscape: The presence of generic and branded competitors will influence pricing, but the combination formulation of Diclofenac Sodium and Misoprostol may maintain a competitive edge.
- Regulatory and Technological Factors: Evolving regulatory frameworks and technological advancements could impact the pricing and market access of this drug.
FAQs
What is the NDC code 75834-0265 used for?
The NDC code 75834-0265 corresponds to Diclofenac Sodium and Misoprostol, a combination drug used to treat pain, inflammation, and stomach ulcers associated with NSAIDs.
What is the projected price inflation for drugs in 2024?
The projected price inflation for drugs in 2024 is 3.8%, driven largely by specialty pharmaceuticals[2].
How does the competitive landscape affect the pricing of Diclofenac Sodium and Misoprostol?
The presence of generic and branded competitors can influence pricing, but the combination formulation of Diclofenac Sodium and Misoprostol may maintain a competitive edge due to its specific therapeutic benefits.
What role do regulatory and technological advancements play in the pricing of this drug?
Regulatory changes and technological advancements can influence pricing and market access by setting new standards for efficacy and safety, although these are more relevant to new drug development.
What is the growth rate of the biopharma market?
The biopharma market is projected to grow at a CAGR of 7.56% between 2024 and 2029[3].
Sources
- DailyMed: NYSTATIN suspension - DailyMed[1]
- Vizient, Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals[2]
- TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025[3]
- Allied Market Research: Incretin-Based Drugs Market Statistics, Forecast - 2032[4]
- FindACode: Nivagen Pharmaceuticals, Inc. - List of Drugs - NDC Labeler[5]
